SYNERGY IN MIXED RIBAVERIN-INTERFERON AQUEOS SOLUTIONS
Abstract
Spectrophotometric method of ribavirin determination in aqueous solutions was improved. Feasibility of ribavirin determination in the presence of protein was confirmed. Colloid-chemistry behavior of ribavirin, interferon and their mixture were investigated. We found that these substances are surface active. The synergistic effect was revealed in ribavirin-interferon mixture in aqueous phase. Particular aspects of ribavirin and interferon adsorption from aqueous phase were specified and characteristics of adsorption layers were determined. We found the influence of ribavervirin on isoelectric point and association parameters of interferon macromolecules.
About the Authors
K. Kienskaya
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
E. Ilyushenko
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
I. Belova
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
M. V. Sardushkin
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
N. Guznova
Polyclinic VIRMED
Russian Federation
Russian Federation
V. Piskunova
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
A. Dremuk
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
R. Ibragimova
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
A. V. Kukharenko
Mendeleev Russian University of Chemical Technology
Russian Federation
Russian Federation
References
1. Раменская Г.В., Шохин И.Е., Кулинич Ю.И. Биофарма-цевтическая классификаия лекарственных веществ. Сеченовский вестник. 2011; 1(3)-2(4): 57-60.
2. Stanimirova R.D., Marinova K.G., Danov K.D. et al. Competitive adsorption of the protein hydrophobin and an ionic surfactant: Parallel vs sequential adsorption and dilatational rheology. Colloids Surf. A. 2014; 457: 307- 317.
3. Narayanan J., Abdul Rasheed A.S., Bellare J.R. A smallangle X-ray scattering study of the structure of lysozymeodium dodecyl sulfate complexes. J. Colloid Interface Sci. 2008; 328(1): 67-72.
4. Samso M., Dabah J., Hansen S., Jones G.R. Evidence for sodium dodecyl sulfate/protein complexes adopting a necklace structure. Eur. J.Biochem. 1995; 232 (3): 818-824.
5. Ghany M.G., Nelson D.R., Strader D.B. et al. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011; 54(4): 1433-1444.
6. Ferenci P., Laferl H., Scherzer T.M. et al. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology. 2008; 135(2): 451-458.
7. Jacobson I.M., McHutchison J.G., Dusheiko G. et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N. Engl. J. Med. 2011; 364(25): 2405-2416.
8. Marukian S. et al. Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology. 2011; 54(6): 1913-1923.
9. Dusheiko G., Nelson D., Reddy K. Ribavirin considerations in treatment optimization. Antivirial Therapy. 2008; 13(1): 23-30.
10. Stryjek-Kaminska D., Ochsendorf F., Rőder C. Photoallergic skin reaction to ribavirin. Am.J. Gastroenterol. 1999; 94(6): 1686-1688.
11. El-Brashy A.M., Sheribah Z.A., Sharaf El-Din M.K., El- Gamal R.M. Kinetic determination of ribavirin in drug formulations. Int. J. Biomed. Sci. 2007; 3(1): 65-71.
12. Austin R.K., Trefts P.E., Hintz M. et al. Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin. Antimicrob. Agents Chemother. 1983; 24(5): 696-701.
13. Sastry C.S.P., Naidu P.I., Lakshmi C.S.R. et al. Application of sodium metaperiodate for the determination of ribavirin in pharmaceutical formulations. Talanta. 1998; 47(1): 85-93.
14. Константинова И.Д., Чудинов М.В., Фатеев И.В и др. Нуклеозиды 1,2,4-триазола: возможности и ограничения химико-ферментативного способа получения. Биоорганическая химия, 2013; 39(1): 61-80.
15. Георгиевский Г.В. Разработка комплекса физико-химических методик, обеспечивающих создание и контроль качества оригинальных отечественных препаратов, производных 1,2,4-триазола. Запорожский медицинский журнал. 2011; 13(1): 58-69.
16. Arnheiter H., Thomas R.M., Leist T. et al. Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferon. Nature. 1981; 294(5838): 278-280.
17. Anantapadmanabhan K.P. Interactions of surfactants with polymers and proteins. Boca Raton, FL: CRC Press. 1993. 427 p.
18. Li F., Rosen M.J., Sulthana S.B. Surface properties of cationic gemini surfactants and their interaction with alkylglucoside or -maltoside surfactants. Langmuir. 2001; 17(4): 1037-1042.
19. Rosen M.J., Zhu Z.H., Gao T. Synergism in binary mixture of surfactants: 11. Mixtures containing mono- and disulfonated alkyland dialkyldiphenylethers. J. Coll. Interf. Sci. 1993; 157(1): 254-258.
20. Чухно А.С., Дмитриева И.Б., Банкина А.Н., Бриллиантова Е.Ю. Изучение взаимодействия белков с биологически активными азотсодержащими гетероциклическими соединениями при различных значениях pH. Бутлеровские сообщения. 2013; 34(5): 91-99.
Review
Views: 334
Email this article 